المؤلفون: Joana Ida Dias, Ana Nóbrega Pinto, Francisco Sousa Vieira, Luís Meireles

المصدر: Acta Médica Portuguesa (2023)

مصطلحات موضوعية: Antitubercular Agents/therapeutic use, Nose Diseases/drug therapy, Tuberculosis/diagnosis, Tuberculosis/drug therapy, Medicine, Medicine (General), R5-920

وصف الملف: electronic resource

Relation: https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/19614; https://doaj.org/toc/0870-399X; https://doaj.org/toc/1646-0758

URL الوصول: https://doaj.org/article/3b2176cad056485ca9acca53867ffbc9

المؤلفون: M. S. Bolhuis, O. W. Akkerman, M. G. G. Sturkenboom, J. F. M. van Boven, J-W. C. Alffenaar, J. Stevens

المساهمون: Microbes in Health and Disease (MHD), Groningen Research Institute for Asthma and COPD (GRIAC), Value, Affordability and Sustainability (VALUE), Real World Studies in PharmacoEpidemiology, -Genetics, -Economics and -Therapy (PEGET), Groningen Kidney Center (GKC)

المصدر: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 27(4), 335-337. International Union against Tubercul. and Lung Dis.

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Infectious Diseases, Diarylquinolines/therapeutic use, Antitubercular Agents/therapeutic use, Humans, Tuberculosis, Tuberculosis, Multidrug-Resistant/complications, Multidrug-Resistant/complications, Diabetes Complications/complications

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::06cbaf522f4d0f2e5fb1f4f16f5a2f36
https://doi.org/10.5588/ijtld.22.0581

المؤلفون: F. Gafar, J-W. C. Alffenaar

المساهمون: PharmacoTherapy, -Epidemiology and -Economics

المصدر: The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease, 27(5), 345-347. International Union against Tubercul. and Lung Dis.

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Drug Combinations, Infectious Diseases, Antitubercular Agents/therapeutic use, Isoniazid, Humans, Child

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6dede552a8d10b245db47a2549e7d28b
https://research.rug.nl/en/publications/8287e515-b96d-465b-a5b0-c46f4512553a

المؤلفون: Singh, Kasha.

مصطلحات موضوعية: Antitubercular agents., Tuberculosis -- Chemotherapy., Antitubercular Agents -- therapeutic use., Tuberculosis -- drug therapy., Tuberculosis -- prevention & control.

المؤلفون: Ma, Zhenkun.

مصطلحات موضوعية: Antitubercular agents., Tuberculosis -- Chemotherapy., Antitubercular Agents -- pharmacology., Antitubercular Agents -- therapeutic use., Tuberculosis -- drug therapy.

المؤلفون: Nunn, Andrew.

مصطلحات موضوعية: Antitubercular agents., Tuberculosis -- Chemotherapy., Tuberculosis -- Treatment., Antitubercular Agents -- therapeutic use., Tuberculosis -- drug therapy.

المؤلفون: Nunn, Paul.

مصطلحات موضوعية: World Health Organization., Global Health., Drug resistance., Multidrug-resistant tuberculosis., Tuberculosis -- Prevention., Antitubercular Agents -- therapeutic use., Communicable Disease Control -- organization & administration., Drug Resistance., International Cooperation., Public Health., Tuberculosis -- drug therapy., Tuberculosis -- prevention & control., Tuberculosis, Multidrug-Resistant.

المساهمون: World Health Organization., World Health Organization, issuing body., Stop TB Initiative (World Health Organization)

مصطلحات موضوعية: Antitubercular Agents -- therapeutic use., Tuberculosis, Pulmonary -- therapy., Antitubercular agents., Tuberculosis -- Chemotherapy., Patient compliance., Tuberculosis -- Drug therapy., Tuberculosis -- Treatment -- Handbooks, manuals, etc., Tuberculosis -- Chemotherapy -- Handbooks, manuals, etc., Tuberculosis -- Patients., Guideline., Handbooks and manuals., Guideline

المؤلفون: Lorenzo Guglielmetti, Gunar Günther, Claude Leu, Daniela Cirillo, Raquel Duarte, Alberto L. Garcia-Basteiro, Delia Goletti, Mateja Jankovic, Liga Kuksa, Florian P. Maurer, Frédéric Méchaï, Simon Tiberi, Frank van Leth, Nicolas Veziris, Christoph Lange

المساهمون: Centre d'Immunologie et des Maladies Infectieuses (CIMI), Institut National de la Santé et de la Recherche Médicale (INSERM)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), Hôpital Avicenne [AP-HP], Centre National de Référence des Mycobactéries et de la Résistance aux Antituberculeux [CHU Pitié-Salpêtrière] (CNR-MyRMA), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), University of Bern, University of Namibia (UNAM), IRCCS San Raffaele Scientific Institute [Milan, Italie], Universidade do Porto = University of Porto, Directorate-General of Health [Lisbonne], Centro de Investigação em Saúde de Manhiça [Maputo, Mozambique] (CISM), Universitat de Barcelona (UB), National Institute for Infectious Diseases 'Lazzaro Spallanzani', Zagreb School of Medicine [Zagreb, Croatia] (Dubrava University Hospital), University of Zagreb, Riga East University Hospital, Riga Stradins University (RSU), Forschungszentrum Borstel - Research Center Borstel, Universitaetsklinikum Hamburg-Eppendorf = University Medical Center Hamburg-Eppendorf [Hamburg] (UKE), German Center for Infection Research - Partner Site Hamburg-Lübeck-Borstel-Riems, German Centre for Infection Research (DZIF), Infection, Anti-microbiens, Modélisation, Evolution (IAME (UMR_S_1137 / U1137)), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPC)-Université Sorbonne Paris Nord, Queen Mary University of London (QMUL), Royal Free Hospital [London, UK], Vrije universiteit = Free university of Amsterdam [Amsterdam] (VU), Amsterdam Public Health Research Institute [The Netherlands], CHU Saint-Antoine [AP-HP], Universität zu Lübeck = University of Lübeck [Lübeck], Baylor College of Medicine (BCM), Baylor University, Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS) and, Tuberculosis Network European Trials group (TBnet), Health Economics and Health Technology Assessment, APH - Global Health, APH - Methodology

المصدر: Study Group on Mycobacteria of the European Society of Microbiology and Infectious Diseases (ESGMYC), European Society of Mycobacteriology (ESM), European Respiratory Society (ERS) & Tuberculosis Network European Trials group (TBnet) 2022, ' Rifapentine access in Europe : growing concerns over key tuberculosis treatment component ', European Respiratory Journal, vol. 59, no. 5, 2200388, pp. 1-3 . https://doi.org/10.1183/13993003.00388-2022
European Respiratory Journal
European Respiratory Journal, European Respiratory Society, 2022, 59 (5), pp.2200388. ⟨10.1183/13993003.00388-2022⟩
European Respiratory Journal, 59(5):2200388, 1-3. European Respiratory Society

مصطلحات موضوعية: Pulmonary and Respiratory Medicine, Antitubercular Agents/therapeutic use, Antitubercular Agents, Tuberculosis / epidemiology, [SDV.MHEP.PSR]Life Sciences [q-bio]/Human health and pathology/Pulmonology and respiratory tract, Drug Therapy, SDG 3 - Good Health and Well-being, Antibiotics, [SDV.MHEP.MI]Life Sciences [q-bio]/Human health and pathology/Infectious diseases, Antibiotics, Antitubercular* / therapeutic use, Tuberculosis, Humans, Rifampin / analogs & derivatives, 610 Medicine & health, Antibiotics, Antitubercular, Antitubercular Agents / therapeutic use, Tuberculosis/drug therapy, Tuberculosis / drug therapy, Rifampin/analogs & derivatives, Antitubercular/therapeutic use, rifapentine, tuberculosis, Europe, Combination, [SDV.SP.PHARMA]Life Sciences [q-bio]/Pharmaceutical sciences/Pharmacology, Drug Therapy, Combination, Rifampin, Rifampin / therapeutic use, Antibiotics, Antitubercular/therapeutic use

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e86ddc6a96141b50eb8c5615420c5f7b
https://hdl.handle.net/1871.1/d90bdc8a-e243-4590-968b-48797208699a

المساهمون: World Health Organization.

مصطلحات موضوعية: Health Planning., Communicable Disease Control., Antitubercular Agents -- therapeutic use., Tuberculosis, Pulmonary -- prevention & control., Guideline.